News Headline Summary

Amgen (AMGN) says its working with FDA on Sensipar development

Reaction details:

- No immediate reaction seen in Co. shares, traded last USD 89.29 (-0.29%)

Print 17:16, 26 Feb 2013 - US Equities - Source: Newswires